Cannabinoid CB1 receptor antagonist rimonabant attenuates reinstatement of ketamine conditioned place preference in rats

European Journal of Pharmacology

Volumn 589, Issue 1-3, 2008, Pages 122-126

  Li, Fangqiong ^a   Fang, Qin ^a   Liu, Yu ^b   Zhao, Mei ^b   Li, Dapeng ^a   Wang, Jishi ^a   Lu, Lin ^b  

^a GUIZHOU MEDICAL UNIVERSITY   (China)

^b PEKING UNIVERSITY   (China)

Author keywords

Cannabinoid CB1 receptor antagonist; Conditioned place preference; Ketamine; Reinstatement; Relapse; Rimonabant

Indexed keywords

'SPECIAL K'; CANNABINOID 1 RECEPTOR; CANNABINOID 1 RECEPTOR ANTAGONIST; COCAINE; DIAMORPHINE; KETAMINE; RIMONABANT; SODIUM CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AVERSION; CONDITIONED REFLEX; CONTROLLED STUDY; DRUG DEPENDENCE TREATMENT; DRUG MEGADOSE; INHIBITION KINETICS; MALE; NONHUMAN; PLACE AVERSION; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; RELAPSE;

ANIMALS; BEHAVIOR, ANIMAL; CONDITIONING (PSYCHOLOGY); DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTINCTION, PSYCHOLOGICAL; INJECTIONS, INTRAPERITONEAL; KETAMINE; MALE; PIPERIDINES; PSYCHOTROPIC DRUGS; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB1; RECURRENCE; SUBSTANCE-RELATED DISORDERS;

EID: 47549102938     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.04.051     Document Type: Article

References (54)

1. Azad S.C., Eder M., Marsicano G., Lutz B., Zieglgansberger W., and Rammes G. Activation of the cannabinoid receptor type 1 decreases glutamatergic and GABAergic synaptic transmission in the lateral amygdala of the mouse. Learn Mem. 10 (2003) 116-128
2. Biala G., and Budzynska B. Reinstatement of nicotine-conditioned place preference by drug priming: effects of calcium channel antagonists. Eur. J. Pharmacol. 537 (2006) 85-93
3. Calcagnetti D.J., and Schechter M.D. Extinction of cocaine-induced place approach in rats: a validation of the "biased" conditioning procedure. Brain Res. Bull. 30 (1993) 695-700
4. Cunningham C.L., Henderson C.M., and Bormann N.M. Extinction of ethanol-induced conditioned place preference and conditioned place aversion: effects of naloxone. Psychopharmacology (Berl.) 139 (1998) 62-70
5. Curran H.V., and Morgan C. Cognitive, dissociative and psychotogenic effects of ketamine in recreational users on the night of drug use and 3 days later. Addiction 95 (2000) 575-590
6. 1 receptors control conditioned drug seeking. Trends Pharmacol. Sci. 26 (2005) 420-426
7. De Vries T.J., Shaham Y., Homberg J.R., Crombag H., Schuurman K., Dieben J., Vanderschuren L.J., and Schoffelmeer A.N. A cannabinoid mechanism in relapse to cocaine seeking. Nat. Med. 7 (2001) 1151-1154
8. De Vries T.J., Homberg J.R., Binnekade R., Raaso H., and Schoffelmeer A.N. Cannabinoid modulation of the reinforcing and motivational properties of heroin and heroin-associated cues in rats. Psychopharmacology (Berl.) 168 (2003) 164-169
9. De Vry J., and Jentzsch K.R. Role of the NMDA receptor NR2B subunit in the discriminative stimulus effects of ketamine. Behav. Pharmacol. 14 (2003) 229-235
10. Di Chiara G., and Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. U. S. A. 85 (1988) 5274-5278
11. Everitt B.J., Parkinson J.A., Olmstead M.C., Arroyo M., Robledo P., and Robbins T.W. Associative processes in addiction and reward. The role of amygdala-ventral striatal subsystems. Ann. N. Y. Acad. Sci. 877 (1999) 412-438
12. Fadda P., Scherma M., Spano M.S., Salis P., Melis V., Fattore L., and Fratta W. Cannabinoid self-administration increases dopamine release in the nucleus accumbens. Neuroreport 17 (2006) 1629-1632
13. Fang Y., Wang Y., Shi J., Liu Z., and Lu L. Recent trends in drug abuse in China. Acta Pharm. Sinica 27 (2006) 140-144
14. 1 receptors in drug addiction: effects of rimonabant on behavioral responses induced by cocaine. Pharmacol. Rep. 58 (2006) 806-819
15. 1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum. J. Neurophysiol. 85 (2001) 468-471
16. Grant K.A., Knisely J.S., Tabakoff B., Barrett J.E., and Balster R.L. Ethanol-like discriminative stimulus effects of non-competitive N-methyl-d-aspartate antagonists. Behav. Pharmacol. 2 (1991) 87-95
17. Huang C.C., Chen Y.L., Lo S.W., and Hsu K.S. Activation of cAMP-dependent protein kinase suppresses the presynaptic cannabinoid inhibition of glutamatergic transmission at corticostriatal synapses. Mol. Pharmacol. 61 (2002) 578-585
18. Kalivas P.W., and McFarland K. Brain circuitry and the reinstatement of cocaine-seeking behavior. Psychopharmacology (Berl.) 168 (2003) 44-56
19. Khanna J.M., Shah G., and Chau A. Effect of NMDA antagonists on rapid tolerance to ethanol under two different testing paradigms. Pharmacol. Biochem. Behav. 57 (1997) 693-697
20. Khanna J.M., Kalant H., Chau A., and Shah G. Effect of NMDA antagonists on development of rapid tolerance to various barbiturates. Alcohol 15 (1998) 9-18
21. Khanna J.M., Morato G.S., and Kalant H. Effect of NMDA antagonists, an NMDA agonist, and serotonin depletion on acute tolerance to ethanol. Pharmacol. Biochem. Behav. 72 (2002) 291-298
22. 1 antagonist, blocks nicotine-conditioned place preferences. Neuroreport 15 (2004) 2139-2143
23. Lu L., Liu D., Ceng X., and Ma L. Differential roles of corticotropin-releasing factor receptor subtypes 1 and 2 in opiate withdrawal and in relapse to opiate dependence. Eur. J. Neurosci. 12 (2000) 4398-4404
24. Lu L., Liu D., and Ceng X. Corticotropin-releasing factor receptor type 1 mediates stress-induced relapse to cocaine-conditioned place preference in rats. Eur. J. Pharmacol. 415 (2001) 203-208
25. Lu L., Zhang B., Liu Z., and Zhang Z. Reactivation of cocaine conditioned place preference induced by stress is reversed by cholecystokinin-B receptors antagonist in rats. Brain Res. 954 (2002) 132-140
26. Lu L., Chen H., Su W., Ge X., Yue W., Su F., and Ma L. Role of withdrawal in reinstatement of morphine-conditioned place preference. Psychopharmacology (Berl.) 181 (2005) 90-100
27. Marquis K.L., Webb M.G., and Moreton J.E. Effects of fixed ratio size and dose on phencyclidine self-administration by rats. Psychopharmacology (Berl.) 97 (1989) 179-182
28. 1 receptors. J. Neurosci. 24 (2004) 53-62
29. Melis T., Succu S., Sanna F., Boi A., Argiolas A., and Melis M.R. The cannabinoid antagonist SR 141716A (Rimonabant) reduces the increase of extra-cellular dopamine release in the rat nucleus accumbens induced by a novel high palatable food. Neurosci. Lett. 419 (2007) 231-235
30. Meyer P.J., and Phillips T.J. Sensitivity to ketamine, alone or in combination with ethanol, is altered in mice selectively bred for sensitivity to ethanol's locomotor effects. Alcohol Clin. Exp. Res. 27 (2003) 1701-1709
31. Mueller D., and Stewart J. Cocaine-induced conditioned place preference: reinstatement by priming injections of cocaine after extinction. Behav. Brain Res. 115 (2000) 39-47
32. Mueller D., Perdikaris D., and Stewart J. Persistence and drug-induced reinstatement of a morphine-induced conditioned place preference. Behav. Brain Res. 136 (2002) 389-397
33. Narita M., Yoshizawa K., Aoki K., Takagi M., Miyatake M., and Suzuki T. A putative sigma1 receptor antagonist NE-100 attenuates the discriminative stimulus effects of ketamine in rats. Addict Biol. 6 (2001) 373-376
34. Ohno-Shosaku T., Shosaku J., Tsubokawa H., and Kano M. Cooperative endocannabinoid production by neuronal depolarization and group I metabotropic glutamate receptor activation. Eur. J. Neurosci. 15 (2002) 953-961
35. Parker L.A., Burton P., Sorge R.E., Yakiwchuk C., and Mechoulam R. Effect of low doses of delta9-tetrahydrocannabinol and cannabidiol on the extinction of cocaine-induced and amphetamine-induced conditioned place preference learning in rats. Psychopharmacology (Berl.) 175 (2004) 360-366
36. Sanchez C.J., and Sorg B.A. Conditioned fear stimuli reinstate cocaine-induced conditioned place preference. Brain Res. 908 (2001) 86-92
37. Shelton K.L., and Balster R.L. Ethanol drug discrimination in rats: substitution with GABA agonists and NMDA antagonists. Behav. Pharmacol. 5 (1994) 441-451
38. Shen M., Piser T.M., Seybold V.S., and Thayer S.A. Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures. J. Neurosci. 16 (1996) 4322-4334
39. Shimoyama N., Shimoyama M., Inturrisi C.E., and Elliott K.J. Ketamine attenuates and reverses morphine tolerance in rodents. Anesthesiology 85 (1996) 1357-1366
40. Silvestre J.S., Pallares M., Nadal R., and Ferre N. Opposite effects of ethanol and ketamine in the elevated plus-maze test in Wistar rats undergoing a chronic oral voluntary consumption procedure. J. Psychopharmacol. 16 (2002) 305-312
41. Suzuki T., Aoki T., Kato H., Yamazaki M., and Misawa M. Effects of the 5-HT(3) receptor antagonist ondansetron on the ketamine- and dizocilpine-induced place preferences in mice. Eur. J. Pharmacol. 385 (1999) 99-102
42. Suzuki T., Kato H., Aoki T., Tsuda M., Narita M., and Misawa M. Effects of the non-competitive NMDA receptor antagonist ketamine on morphine-induced place preference in mice. Life Sci. 67 (2000) 383-389
43. Szabo B., Wallmichrath I., Mathonia P., and Pfreundtner C. Cannabinoids inhibit excitatory neurotransmission in the substantia nigra pars reticulata. Neuroscience 97 (2000) 89-97
44. Tanda G., Pontieri F.E., and Di Chiara G. Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism. Science 276 (1997) 2048-2050
45. Trujillo K.A., and Akil H. Inhibition of opiate tolerance by non-competitive N-methyl-d-aspartate receptor antagonists. Brain Res. 633 (1994) 178-188
46. Trujillo K.A., Zamora J.J., and Warmoth K.P. Increased response to ketamine following treatment at long intervals: implications for intermittent use. Biol. Psychiatry 11 (2007) 11
47. Tzschentke T.M. Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues. Prog. Neurobiol. 56 (1998) 613-672
48. Tzschentke T.M. Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade. Addict Biol. 12 (2007) 227-462
49. Uchihashi Y., Kuribara H., Morita T., and Fujita T. The repeated administration of ketamine induces an enhancement of its stimulant action in mice. Jpn. J. Pharmacol. 61 (1993) 149-151
50. Wang J., Fang Q., Liu Z., and Lu L. Region-specific effects of brain corticotropin-releasing factor receptor type 1 blockade on footshock-stress- or drug-priming-induced reinstatement of morphine conditioned place preference in rats. Psychopharmacology (Berl.) 185 (2006) 19-28
51. Wiley J.L., Evans R.L., Grainger D.B., and Nicholson K.L. Age-dependent differences in sensitivity and sensitization to cannabinoids and 'club drugs' in male adolescent and adult rats. Addict Biol. 11 (2007) 11
52. Winger G., Palmer R.K., and Woods J.H. Drug-reinforced responding: rapid determination of dose-response functions. Drug Alcohol Depend. 24 (1989) 135-142
53. Wolff K., and Winstock A.R. Ketamine: from medicine to misuse. CNS Drugs 20 (2006) 199-218
54. Zhao M., Zhang Z.Y., Zhai H.F., Qiu Y., and Lu L. Effects of stress during reactivation on rewarding memory. Neuroreport 18 (2007) 1153-1156